Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | C10orf28 |
| Upstream (Parents) |
|---|
| (<<) SYNJ1 → C10orf28 |
| (<<) ATP13A3 → C10orf28 |
| (<<) MBNL2 → C10orf28 |
| (<<) ZFY///ZFX → C10orf28 |
| (<<) NEK9 → C10orf28 |
| (<<) FAM108B1 → C10orf28 |
| Downstream (Children) |
|---|
| C10orf28 → ATP6V0A1 (>>) |
| C10orf28 → SLC4A3 (>>) |
| C10orf28 → SYNJ1 (>>) |
| C10orf28 → MBNL2 (>>) |
| C10orf28 → ADRBK1 (>>) |
| C10orf28 → PXN (>>) |
| C10orf28 → IRF4 (>>) |
| C10orf28 → PPM1E (>>) |
| C10orf28 → PBOV1 (>>) |
| C10orf28 → TGFB2 (>>) |
| C10orf28 → PAK7 (>>) |
| C10orf28 → CLCN4 (>>) |
| C10orf28 → OR10C1 (>>) |
| C10orf28 → LOC654056///SIRPB1 (>>) |
| C10orf28 → VPS13B (>>) |
| C10orf28 → MED28 (>>) |
| C10orf28 → TOP3A (>>) |
| C10orf28 → ATP2B4 (>>) |
| C10orf28 → VCPIP1 (>>) |
| C10orf28 → PTPN11 (>>) |
| C10orf28 → GPR39 (>>) |
| C10orf28 → NEK9 (>>) |
| C10orf28 → FAM108B1 (>>) |
| C10orf28 → MAP3K1 (>>) |
